Ozempic 0.25 mg Dosing
A patient on Ozempic 0.25 mg should inject exactly 0.25 mg once weekly, subcutaneously, on the same day each week. 1
Understanding the 0.25 mg Dose
The 0.25 mg dose is not a therapeutic dose—it is specifically designed as an initiation dose only and is not effective for glycemic control 1. This is a critical point that is often misunderstood.
Standard Dosing Algorithm
According to FDA-approved prescribing information and clinical guidelines 2, 3, 1:
- Weeks 1-4: Inject 0.25 mg once weekly (initiation dose)
- After 4 weeks: Increase to 0.5 mg once weekly
- After at least 4 additional weeks on 0.5 mg: May increase to 1 mg once weekly if additional glycemic control is needed
- Maximum dose: 1 mg once weekly for diabetes 1; 2.4 mg once weekly for weight management 4
Administration Details
Injection technique 1:
- Administer subcutaneously to the abdomen, thigh, or upper arm
- Inject on the same day each week, at any time of day, with or without meals
- Use a different injection site each week within the same body region
- The day of weekly administration can be changed if at least 2 days (>48 hours) pass between doses
If a dose is missed 1:
- Administer as soon as possible within 5 days after the missed dose
- If more than 5 days have passed, skip the missed dose and resume the regular schedule
Why Gradual Titration Matters
The dose escalation from 0.25 mg is essential to minimize gastrointestinal adverse effects, particularly nausea and vomiting 3. Rushing this titration significantly increases the risk of intolerable side effects that may lead to treatment discontinuation.
Common Pitfall to Avoid
Do not remain on 0.25 mg long-term. This dose provides no meaningful glycemic benefit or cardiovascular risk reduction 1. Patients must advance to at least 0.5 mg after 4 weeks to achieve therapeutic effects on glucose control, weight reduction, and cardiovascular outcomes 2.
Special Considerations
No renal dose adjustment required 2—semaglutide can be used across all levels of kidney function without dose modification, which distinguishes it from some other diabetes medications.
For weight management specifically 4: The titration continues monthly up to 2.4 mg weekly (0.25 mg → 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg), with each dose maintained for 4 weeks before escalation.